We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
-12.95%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$576M
AUM Growth
-$318M
Cap. Flow
-$237M
Cap. Flow %
-41.05%
Top 10 Hldgs %
8.59%
Holding
715
New
166
Increased
176
Reduced
142
Closed
157

Sector Composition

Rank Sector Weight
1 Financials 19.33%
2 Technology 14.61%
3 Healthcare 13.93%
4 Industrials 12.75%
5 Energy 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
476
DELISTED
Comerica
CMA
$244K 0.04%
3,319
-362
-10% -$29.2K
HLF icon
477
Herbalife
HLF
$1.21B
$239K 0.04%
11,705
-172
-1% -$4.25K
PW
478
Power REIT
PW
$2.99M
$232K 0.04%
1,821
+1,251
+219% +$303K
WAL icon
479
Western Alliance Bancorporation
WAL
$8.78B
$231K 0.04%
+3,276
New +$251K
REPX icon
480
Riley Exploration Permian
REPX
$802M
$227K 0.04%
+9,402
New +$241K
SJM icon
481
J.M. Smucker
SJM
$12.6B
$226K 0.04%
1,762
-28
-2% -$3.73K
FHN icon
482
First Horizon
FHN
$12B
$224K 0.04%
10,235
AKAM icon
483
Akamai
AKAM
$16.9B
$221K 0.04%
2,425
-1,068
-31% -$111K
IDYA icon
484
IDEAYA Biosciences
IDYA
$3.54B
$219K 0.04%
+15,896
New +$177K
TTEK icon
485
Tetra Tech
TTEK
$8.97B
$217K 0.04%
7,935
SBUX icon
486
Starbucks
SBUX
$119B
$211K 0.04%
2,772
-17,783
-87% -$1.37M
OLMA icon
487
Olema Pharmaceuticals
OLMA
$1.04B
$208K 0.04%
+51,152
New +$162K
HBAN icon
488
Huntington Bancshares
HBAN
$35.6B
$204K 0.04%
16,945
-5,003
-23% -$66.4K
HPE icon
489
Hewlett Packard
HPE
$72.4B
$196K 0.03%
14,765
-563
-4% -$8.54K
PLRX icon
490
Pliant Therapeutics
PLRX
$64.4M
$194K 0.03%
+24,280
New +$155K
DYN icon
491
Dyne Therapeutics
DYN
$4.95B
$190K 0.03%
+27,651
New +$190K
MRSN
492
DELISTED
Mersana Therapeutics
MRSN
$187K 0.03%
+1,619
New +$152K
STTK icon
493
Shattuck Labs
STTK
$682M
$182K 0.03%
+44,842
New +$162K
ANNX icon
494
Annexon
ANNX
$883M
$167K 0.03%
+44,419
New +$136K
NKTR icon
495
Nektar Therapeutics
NKTR
$2.53B
$167K 0.03%
+2,932
New +$185K
FMTX
496
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$164K 0.03%
+23,747
New +$167K
GBIO
497
DELISTED
Generation Bio
GBIO
$163K 0.03%
+2,486
New +$163K
IMGN
498
DELISTED
Immunogen Inc
IMGN
$161K 0.03%
+35,751
New +$155K
PASG icon
499
Passage Bio
PASG
$13.9M
$158K 0.03%
+3,355
New +$157K
QTTB icon
500
Q32 Bio
QTTB
$466M
$157K 0.03%
+4,441
New +$152K

Similar funds

Cornercap Investment Counsel's Q2 2022 Portfolio in Review

As of Q2 2022, Cornercap Investment Counsel held 715 positions worth $576M, down 36% from $895M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Cornercap Investment Counsel withdrew a net $237M in Q2 2022, closing 157 positions and reducing 142 holdings. Its most notable exit was CornerCap Fundametrics Large-Cap ETF, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cornercap Investment Counsel opened a new position in CBRE Group worth $1.99M.

  • Cornercap Investment Counsel's largest Q2 2022 buy was CBRE Group: 27,056 shares worth $1.99M.
  • Cornercap Investment Counsel added most to Comcast in Q2 2022, an estimated $1.9M increase.
  • Cornercap Investment Counsel's biggest Q2 2022 reduction was Eastman Chemical, cutting an estimated $3.82M.
  • Cornercap Investment Counsel fully exited CornerCap Fundametrics Large-Cap ETF in Q2 2022, selling an estimated $117M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.6% of its $576M portfolio in Q2 2022.
  • Cornercap Investment Counsel opened 166 new positions and closed 157 in Q2 2022.
  • Cornercap Investment Counsel's portfolio value fell 36% quarter-over-quarter to $576M.

Based on Cornercap Investment Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.